Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial - Wikidata - awgldk - TriplyDB

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

http://www.wikidata.org/entity/Q28305038

about

Locoregional treatment of early breast cancer with isolated tumor cells or micrometastases on sentinel lymph node biopsy Gaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of Life Oncologic safety of conservative mastectomy in the therapeutic setting Axillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analyses Breast cancer: news in diagnosis and treatment Postmastectomy radiation therapy after neoadjuvant chemotherapy: review and interpretation of available data New trends in breast cancer surgery: a therapeutic approach increasingly efficacy and respectful of the patient Sentinel Lymph Node in Breast Cancer: Review Article from a Pathologist's Point of View Radiotherapy of the Lymphatic Pathways in Early Breast Cancer Early-Stage Breast Cancer in the Elderly: Confronting an Old Clinical Problem Management of early breast cancer in older women: from screening to treatment Landmark trials affecting the surgical management of invasive breast cancer Nomograms in oncology: more than meets the eye Performance characteristics of ultrasound-guided fine-needle aspiration of axillary lymph nodes for metastatic breast cancer employing rapid on-site evaluation of adequacy: analysis of 136 cases and review of the literature The evolution of the locoregional therapy of breast cancer Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance Mapping lymph nodes in cancer management - role of (99m)Tc-tilmanocept injection Adjunct primer for the use of national comprehensive cancer network guidelines for the surgical management of cutaneous malignant melanoma patients Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients: from preclinical evaluation to clinical validation Optimal management of breast cancer in the elderly patient: current perspectives Improving systemic breast cancer therapy: time to look beyond the primary tumour?Management of Axilla in 2015 in Indian Scenario Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Emergent complexity of the cytoskeleton: from single filaments to tissue Axillary treatment for operable primary breast cancer.[Good Prognosis! Breast Cancer Update 2016].13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.Contrast-enhanced sonography for detection of secondary lymph nodes in a melanoma tumor animal model A practical approach to imaging the axilla Three-dimensional quantitative ultrasound for detecting lymph node metastases.Multimodal sentinel lymph node mapping with single-photon emission computed tomography (SPECT)/computed tomography (CT) and photoacoustic tomography Real-time ultrasound elastography in 180 axillary lymph nodes: elasticity distribution in healthy lymph nodes and prediction of breast cancer metastases.Sentinel node mapping for breast cancer: current situation Lymphatic abnormalities in the normal contralateral arms of subjects with breast cancer-related lymphedema as assessed by near-infrared fluorescent imaging.Axillary lymph node dissection for breast cancer utilizing Harmonic Focus®Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 No Survival Benefit for Patients with Treatment in Certified Breast Centers-A Population-based Evaluation of German Cancer Registry Data.Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.

P2860

Q26747688-29FCF558-7DCD-4FFB-803F-5666326F7109 Q26751574-079E5F14-6067-4BCF-B044-19E0794C8661 Q26768209-A8F9A399-77E7-438C-B9DE-41343A5A060D Q26768675-7DD0E52B-FF03-4022-82D2-B056C5724C99 Q26769677-9C102D9B-6C38-4177-A91F-266DA96681F0 Q26769835-CC4176EF-C972-40C0-BBD3-280026209B94 Q26771845-9ADEB9D8-1C45-458F-B6E2-96C6E7EE6823 Q26772240-3CBB32B4-A3E6-4ACF-8803-8CFD041FB4D9 Q26776280-C60AD228-65CA-40BA-895D-E24A21EE4842 Q26782584-4DAA3EAF-BE11-4E5F-85C3-C164B217DED0 Q26799695-7763AD40-8A65-4428-AED4-938FFDA69A63 Q26830129-7E4EED39-58FB-4C2F-8C00-B9937FEE3DB3 Q26830260-7EF52879-0563-4EDB-8672-32B1ECFDEDC4 Q26852867-13766F27-F7D6-4559-934C-7F8DAD40A3EC Q26992321-02D3FBE7-A704-468A-9578-16EB3846F630 Q26996059-294F8D68-A9A3-4BFB-BD4A-97908B9324E6 Q27001564-26B507AB-E2F0-40F3-B9C4-9AD75B9EF13D Q27022042-453BE3C8-4495-4185-AB68-95E93DEB36FD Q27025460-8EDDB518-CE24-4508-9B03-19561D43215D Q27336227-7A4E4DA4-B33B-4A84-BC6C-E17AF40D258B Q27690879-9B50F433-76F9-45A8-957B-047DB59DF7EC Q28078275-0666A0D4-E452-433C-876D-E615F2247181 Q28079495-8B1DE557-E953-4AFA-A65E-D1ED7C01E7E7 Q28085062-452CA534-6837-45A9-9FC1-A9C74F43CA49 Q28238533-C09E2B2F-83CF-48F8-A912-1BB4EAAAD6FA Q30239832-D5BB85AD-C447-4081-ABAB-5092D88B1A5F Q30249775-EAE624C9-391E-45CB-9C8E-0745A0C0B608 Q30317570-80D39ED4-5A06-4AC9-BE9D-8EFF625E1530 Q30318240-19C101AB-B1C6-48EA-9263-5DB46A8126CE Q30413821-2D9F58C3-23CC-479E-86CE-D7139007A2B1 Q30415701-251E8AE9-8586-47EE-884D-AEA997EC9D86 Q30435780-698EDAF9-BD69-41BD-B001-4C9BEDBB2563 Q30457846-4F66B760-5B50-4478-B6A5-64A73BC55EEF Q30459293-23E1CD32-F2F6-44D2-8FD7-7BD2093D41B9 Q30464471-80C39608-2466-4F3A-973D-797B97F151C2 Q30466366-75CA328A-FCA1-4137-B608-21DB206EFB25 Q30474173-D199E3CE-6F0B-44B0-9387-BD79A8967D11 Q30543788-19E83C81-B2EB-459B-BAF9-461CEDEAF636 Q30977803-0864ED82-DF5A-4137-8FB0-CD2F4BB879FA Q31022615-EB0F001D-9806-4375-A34E-BAAE3C48F1EA

P2860

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

http://www.wikidata.org/entity/Q28305038

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Axillary dissection vs no axil ...... s: a randomized clinical trial

@ast

Axillary dissection vs no axil ...... s: a randomized clinical trial

@en

Axillary dissection vs no axil ...... s: a randomized clinical trial

@nl

type

label

Axillary dissection vs no axil ...... s: a randomized clinical trial

@ast

Axillary dissection vs no axil ...... s: a randomized clinical trial

@en

Axillary dissection vs no axil ...... s: a randomized clinical trial

@nl

prefLabel

Axillary dissection vs no axil ...... s: a randomized clinical trial

@ast

Axillary dissection vs no axil ...... s: a randomized clinical trial

@en

Axillary dissection vs no axil ...... s: a randomized clinical trial

@nl

P1433

Q28305038-6F200744-5D2A-4970-9EBB-D885F407D62B

P1476

Q28305038-B2D5E3A2-5246-498F-90D6-5EFBEA0E49C0

P2093

Q28305038-1588E0A3-8309-403C-A7D2-356E864429BE

Q28305038-2F7B461C-7AB5-49B2-B96B-9F26E814E7BC

Q28305038-7484F216-FA88-47B3-80C5-FB537525B7C8

Q28305038-7D2E20A4-FC07-4F47-9B2D-DB514428D928

Q28305038-B9AD41EC-FE98-4DF3-A951-F39080719805

Q28305038-C3517BE5-98ED-450A-B84A-84D100411739

Q28305038-CA604338-0A50-4267-AC8E-7AD6911BD87F

Q28305038-D5F08A61-F9F2-4E6C-8298-2864B47C7BB0

Q28305038-D9A8B5D4-0DB4-4488-A31C-B7144F72B79E

P2860

Q28305038-12A40048-C1C6-4B01-85D0-A285134019B4

Q28305038-2FE90BAF-0FEF-4E15-9DD2-FE685372422A

Q28305038-34442B0B-D889-41F8-919D-08A3BC8B6FA7

Q28305038-370F9A55-8A29-4C10-9E42-9EF77C611585

Q28305038-4A1E75B8-8683-4124-B5EB-DCA8D53F5B4C

Q28305038-4B2B1EBB-3484-4AF2-B4E6-8EA6D433C688

Q28305038-4B846184-0E01-4F6C-A3C7-74729FFF6C6C

Q28305038-4F6913E0-50F2-4331-BA95-EBBA2B5D5D95

Q28305038-50101605-B58B-4BF8-9B6D-CB55D0D9B925

Q28305038-5A477332-59F8-4A2F-A1B3-C38C370997A1

P304

Q28305038-FFF5DAB0-313A-40D5-A95F-DBAFD47DA99A

P31

Q28305038-E555D533-1A5D-4C84-AA49-87A559659012

P3181

Q28305038-07DD6873-415C-4ECB-A626-5BC59FF7A570

P356

Q28305038-F6B04B6D-A12F-4B99-BC30-C181E1FD36B3

P407

Q28305038-E5D805DA-B0DC-4F22-8BFB-57DCEB847A8F

P433

Q28305038-210D5EB6-CB02-42C6-9BB8-B16C77BA19C7

P478

Q28305038-7ED846F0-155D-46DE-B889-7C480372ECED

P50

Q28305038-148D3464-0866-4676-A031-8A06D7250496

P577

Q28305038-54D4C1D2-643B-4870-BDEC-28D1EB01594B

P5875

Q28305038-DF38A59E-0594-4ECC-8E96-EBD2A0035B6E

P698

Q28305038-DE5DC7F4-590A-4150-9378-720F7547D4EF

P932

Q28305038-E136DD1F-4FD6-4CDE-B356-958527440EA0

P3181

P356

P1433

Journal of the American Medical Association

P1476

Axillary dissection vs no axil ...... s: a randomized clinical trial

@en

P2093

A Marilyn Leitch

http://www.w3.org/2001/XMLSchema#string

Armando E Giuliano

http://www.w3.org/2001/XMLSchema#string

Karla V Ballman

http://www.w3.org/2001/XMLSchema#string

Kelly K Hunt

http://www.w3.org/2001/XMLSchema#string

Linda M McCall

http://www.w3.org/2001/XMLSchema#string

Pat W Whitworth

http://www.w3.org/2001/XMLSchema#string

Peter D Beitsch

http://www.w3.org/2001/XMLSchema#string

Peter W Blumencranz

http://www.w3.org/2001/XMLSchema#string

Sukamal Saha

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

A gene-expression signature as a predictor of survival in breast cancer

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up

Adjuvant therapy for breast cancer--results from the USA consensus conference.

P304

569-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

727098

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMA.2011.90

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

305

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49820158

http://www.w3.org/2001/XMLSchema#string

P698

21304082

http://www.w3.org/2001/XMLSchema#string

P932

5389857

http://www.w3.org/2001/XMLSchema#string